Mathew Wallis,Simon D Bodek,Jacob Munro,Haloom Rafehi,Mark F Bennett,Zimeng Ye,Amy Schneider,Fiona Gardiner,Giulia Valente,Emma Murdoch,Eloise Uebergang,Jacquie Hunter,Chloe Stutterd,Aamira Huq,Lucinda Salmon,Ingrid Scheffer,Dhamidhu Eratne,Stephen Meyn,Chun Y Fong,Tom John,Saul Mullen,Susan M White,Natasha J Brown,George McGillivray,Jesse Chen,Chris Richmond,Andrew Hughes,Emma Krzesinski,Andrew Fennell,Brian Chambers,Renee Santoreneos,Anna Le Fevre,Michael S Hildebrand,Melanie Bahlo,John Christodoulou,Martin Delatycki,Samuel F Berkovic

Abstract:Background: Significant recent efforts have facilitated increased access to clinical genetics assessment and genomic sequencing for children with rare diseases in many centres, but there remains a service gap for adults. The Austin Health Adult Undiagnosed Disease Program (AHA-UDP) was designed to complement existing UDP programs that focus on paediatric rare diseases and address an area of unmet diagnostic need for adults with undiagnosed rare conditions in Victoria, Australia. It was conducted at a large Victorian hospital to demonstrate the benefits of bringing genomic techniques currently used predominantly in a research setting into hospital clinical practice, and identify the benefits of enrolling adults with undiagnosed rare diseases into a UDP program. The main objectives were to identify the causal mutation for a variety of diseases of individuals and families enrolled, and to discover novel disease genes. Methods: Unsolved patients in whom standard genomic diagnostic techniques such as targeted gene panel, exome-wide next generation sequencing, and/or chromosomal microarray, had already been performed were recruited. Genome sequencing and enhanced genomic analysis from the research setting were applied to aid novel gene discovery. Results: In total, 16/50 (32%) families/cases were solved. One or more candidate variants of uncertain significance were detected in 18/50 (36%) families. No candidate variants were identified in 16/50 (32%) families. Two novel disease genes (TOP3B, PRKACB) and two novel genotype-phenotype correlations (NARS, and KMT2C genes) were identified. Three out of eight patients with suspected mosaic tuberous sclerosis complex had their diagnosis confirmed which provided reproductive options for two patients. The utility of confirming diagnoses for patients with mosaic conditions (using high read depth sequencing and ddPCR) was not specifically envisaged at the onset of the project, but the flexibility to offer recruitment and analyses on an as-needed basis proved to be a strength of the AHA-UDP. Conclusion: AHA-UDP demonstrates the utility of a UDP approach applying genome sequencing approaches in diagnosing adults with rare diseases who have had uninformative conventional genetic analysis, informing clinical management, recurrence risk, and recommendations for relatives.

Diagnosis of "mystery" conditions improves with advanced US network approach.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Accelerating rare disease detection: an experience of multidisciplinary team model in undiagnosed diseases program in a children's hospital

Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations

Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant

Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless

Prevalence of Individuals With Multiple Diagnosed Genetic Diseases in the Undiagnosed Diseases Network

A review of multiple diagnostic approaches in the undiagnosed diseases network to identify inherited metabolic diseases

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Advancing Equity in Rare Disease Research: Insights From the Undiagnosed Disease Network

Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions

Implementing genomic medicine in clinical practice for adults with undiagnosed rare diseases

Enhancing Variant of Uncertain Significance (VUS) Interpretation in Neurogenetics: Collaborative Experiences from a Tertiary Care Centre

Beyond the exome: what's next in diagnostic testing for Mendelian conditions

Integrated multi-omics for rapid rare disease diagnosis on a national scale

Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing

Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare system

Exploring the journey to genomic testing and genetic services: A qualitative study of parental perspectives of children with rare conditions

Specialist referrals and diagnostic delays in motor neurone disease: Mapping patients' journey through hoops and hurdles in healthcare

Diagnostic yield of advanced genetic testing in patients with hereditary neuropathies: A retrospective single-site study